LVTX · Categories · Form 4

LVTX - SEC Form 4 insider transactions

LAVA Therapeutics N.V. (LVTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for LVTX

• 198d
  Chief Financial Officer Powell Fred M returned 65,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 198d
  SEC Form 4 filed by Director Oliger Christy J.

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 198d
  SEC Form 4 filed by Director Wadlinger Mary E.

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 198d
  Director Wilson Karen J returned 10,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 198d
  Director Dhingra Kapil returned 30,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 198d
  SEC Form 4 filed by Director Backstrom Jay T.

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 198d
  SEC Form 4 filed by Director Noble James

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 198d
  SEC Form 4 filed by Director Kiener Peter A

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 198d
  Chief Executive Officer Hurly Stephen A returned 5,000 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 226d
  Large owner Cooperatieve Gilde Healthcare Iv U.A. sold $4,224,719 worth of shares (2,871,370 units at $1.47) (SEC Form 4)

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 231d
  Large owner Cooperatieve Gilde Healthcare Iv U.A. sold $718,721 worth of shares (475,027 units at $1.51) (SEC Form 4)

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 236d
  Large owner Cooperatieve Gilde Healthcare Iv U.A. sold $197,898 worth of shares (126,992 units at $1.56) (SEC Form 4)

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 253d
  Large owner Versant Venture Capital Vi, L.P. sold $4,068,829 worth of shares (2,903,403 units at $1.40) (SEC Form 4)

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 258d
  Large owner Versant Venture Capital Vi, L.P. sold $2,502,261 worth of shares (1,684,434 units at $1.49) (SEC Form 4)

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 470d
  SEC Form 4 filed by Director Wilson Karen J

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 470d
  SEC Form 4 filed by Director Backstrom Jay T.

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 470d
  SEC Form 4 filed by Director Kiener Peter A

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 470d
  SEC Form 4 filed by Director Noble James

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 470d
  SEC Form 4 filed by Director Wadlinger Mary E.

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 470d
  SEC Form 4 filed by Chief Financial Officer Powell Fred M

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 470d
  SEC Form 4 filed by Director Dhingra Kapil

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 470d
  SEC Form 4 filed by Chief Medical Officer Morris Charles Q

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 470d
  SEC Form 4 filed by Director Oliger Christy J.

  4 - LAVA Therapeutics NV (0001840748) (Issuer)
• 470d
  SEC Form 4 filed by Chief Executive Officer Hurly Stephen A

  4 - LAVA Therapeutics NV (0001840748) (Issuer)

Other LVTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends